Argenica Therapeutics

Developer of neuroprotective therapeutics for stroke and neural injuries

placeNedlands, Western Australia, Australia calendar_todayFounded 2019 language argenica.com.au

Innovation

1 patent family (1 granted) — focus: Human necessities; filing pace steady. Cited 348 times.

YearFilings
20221
20251

Social engagement

Social engagement: 2.9K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

1 investor on record.

Investor typeCountShare
Other / undisclosed1100%

Recent activity

12 Jun 2026
Product launch
hERG assay (xaranetide)
10 Jun 2026
Milestone
regulatory
25 May 2026
Partnership
Emergency Stroke Organisation Conference (ESOC)
Coming soon